Seoul, South Korea Saturday, March 29, 2025, 14:00 Hrs [IST] ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

Southside Cancer Care Centre in Miranda initiated as first site for Race’s Phase I trial of cardioprotective therapy RC220 in ...

The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

The management of breast cancer involves various therapeutic approaches. However, many current anticancer treatments indiscriminately damage both cancerous and healthy cells. In cancer treatment, ...

Created in 1992, the FDA's accelerated approval pathway allows an initial approval of drugs for serious or life-threatening ...

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

Halting the relentless march of so-called 'zombie cells' that drive aging and age-related diseases could be a step closer ...

Over the years, there has been an increasing demand for an effective and cost-efficient drug discovery process. The study of ...

FLuID enables privacy-preserving knowledge sharing in drug discovery using knowledge distillation. The results show that the approach expands applicability domains and fosters collaboration across ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.